Intercept Pharmaceuticals (NASDAQ:ICPT) Coverage Initiated at assumed coverage on shares of Intercept Pharmaceuticals (NASDAQ:ICPT – Free Report) in a research note released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on ICPT. Canaccord Genuity Group reiterated a hold rating and issued a $19.00 price objective (down from […]

Leave a Reply

Your email address will not be published.

Previous post Huntington Bancshares (NASDAQ:HBAN) Stock Rating Lowered by
Next post Championship or bust: 5 keys for Celtics as pursuit of long-awaited title begins